The Centers for Disease Control and Prevention (CDC) has partnered with HP to use the company’s new BioPrinters to test bacterial pathogens for resistance to specific antibiotic samples. The HP D300e Digital Dispenser BioPrinters are being used as part of the Antibiotic Resistance Lab Network to create better tools to address developing antibiotic resistance in emerging bugs.
“Bacteria continuously develop new ways to resist antibiotics—once a drug is approved for use, the countdown begins until resistance emerges. In fact, resistance has even been detected before FDA approval,” in a statement said Jean Patel, PH.D., Science Team Lead at Antibiotic Resistance Coordination and Strategy Unit at the CDC. “To save lives and protect people, it is vital to make technology accessible to hospital labs nationwide. We hope this pilot will help ensure our newest drugs last longer and put gold-standard lab results in healthcare providers’ hands faster.”
The HP BioPrinters release small, accurately measured amounts (picoliters to microliters) of substances, which can be made to interact with bacteria and assessed using additional equipment. The underlying technology in the BioPrinters relies on a lot of the knowledge obtained building inkjet printers, something HP is well known for. The devices are being provided to labs in Wisconsin, Minnesota, Tennessee, and New York states.
Here’s an HP video about the new BioPrinters:
Product page: HP D300e Digital Dispenser…
Via: HP…